109 related articles for article (PubMed ID: 7699885)
1. [The mechanisms of myeloma cell growth].
Shimizu S
Nihon Rinsho; 1995 Mar; 53(3):557-63. PubMed ID: 7699885
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of multiple myeloma cell growth].
Simizu S; Konda S
Rinsho Ketsueki; 1993 Apr; 34(4):418-22. PubMed ID: 8510327
[TBL] [Abstract][Full Text] [Related]
3. Homing mechanisms in the biology of multiple myeloma.
Van Camp B; Van Riet I
Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
[TBL] [Abstract][Full Text] [Related]
4. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
6. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of IL-6-LIKE cytokines in normal bone marrow: implications for pathophysiology of myeloma.
Barton BE; Murphy TF
Cytokine; 2000 Oct; 12(10):1537-45. PubMed ID: 11023670
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the in vitro evolution of a myeloma cell line.
Scibienski RJ; Paglieroni T; Caggiano V; Lemongello D; Gumerlock PH; Mackenzie MR
Leukemia; 1992 Sep; 6(9):940-7. PubMed ID: 1518305
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a human myeloma cell line with growth-promoting activity for bone marrow-derived fibroblastoid colony-forming cells.
Takahira H; Kozuru M; Hirata J; Obama K; Uike N; Iguchi H; Miyamura T; Yamashita S; Kono A; Umemura T
Exp Hematol; 1994 Mar; 22(3):261-6. PubMed ID: 8112425
[TBL] [Abstract][Full Text] [Related]
10. Interaction between a murine myeloma cell line and bone marrow stromal cells.
Bradley TR; Kriegler AB; Verschoor SM; Tzelepis SM; Cooper IA
Exp Hematol; 1996 Feb; 24(2):307-9. PubMed ID: 8641357
[TBL] [Abstract][Full Text] [Related]
11. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
12. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell- and marrow stromal cell-specific requirements for gamma irradiation leukemogenesis in vitro.
Greenberger JS; Wright E; Henault S; Anklesaria P; Leif J; Sakakeeny MA; FitzGerald TJ; Pierce JH; Kase K
Exp Hematol; 1990 Jun; 18(5):408-15. PubMed ID: 2186923
[TBL] [Abstract][Full Text] [Related]
14. Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.
Billadeau D; Liu P; Jelinek D; Shah N; LeBien TW; Van Ness B
Cancer Res; 1997 Jun; 57(11):2268-75. PubMed ID: 9187131
[TBL] [Abstract][Full Text] [Related]
15. The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone.
Grigorieva I; Thomas X; Epstein J
Exp Hematol; 1998 Jul; 26(7):597-603. PubMed ID: 9657134
[TBL] [Abstract][Full Text] [Related]
16. Human bone marrow stromal cell lines from myeloma and rheumatoid arthritis that can support murine pre-B cell growth.
Kaisho T; Oritani K; Ishikawa J; Tanabe M; Muraoka O; Ochi T; Hirano T
J Immunol; 1992 Dec; 149(12):4088-95. PubMed ID: 1281201
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines.
Sakagami Y; Girasole G; Yu XP; Boswell HS; Manolagas SC
J Bone Miner Res; 1993 Jul; 8(7):811-6. PubMed ID: 8394639
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
[TBL] [Abstract][Full Text] [Related]
19. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]